224 related articles for article (PubMed ID: 30954027)
1. Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2.
Resende ATP; Martins CS; Bueno AC; Moreira AC; Foss-Freitas MC; de Castro M
Clin Endocrinol (Oxf); 2019 Jul; 91(1):94-103. PubMed ID: 30954027
[TBL] [Abstract][Full Text] [Related]
2. Irisin levels in LMNA-associated partial lipodystrophies.
Bensmaïne F; Benomar K; Espiard S; Vahe C; Le Mapihan K; Lion G; Lemdani M; Chazard E; Ernst O; Vigouroux C; Pigny P; Vantyghem MC
Diabetes Metab; 2019 Jan; 45(1):67-75. PubMed ID: 30165155
[TBL] [Abstract][Full Text] [Related]
3. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism.
Friesen M; Cowan CA
Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996
[TBL] [Abstract][Full Text] [Related]
4. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety.
Vasandani C; Li X; Sekizkardes H; Adams-Huet B; Brown RJ; Garg A
J Clin Endocrinol Metab; 2020 Jul; 105(7):2132-41. PubMed ID: 32193531
[TBL] [Abstract][Full Text] [Related]
6. Regional Body Fat Changes and Metabolic Complications in Children With Dunnigan Lipodystrophy-Causing LMNA Variants.
Patni N; Li X; Adams-Huet B; Vasandani C; Gomez-Diaz RA; Garg A
J Clin Endocrinol Metab; 2019 Apr; 104(4):1099-1108. PubMed ID: 30418556
[TBL] [Abstract][Full Text] [Related]
7. Describing the natural history of clinical, biochemical and radiological outcomes of children with familial partial lipodystrophy type 2 (FPLD2) from the United Kingdom: A retrospective case series.
Zhong ZX; Harris J; Wilber E; Gorman S; Savage DB; O'Rahilly S; Stears A; Williams RM
Clin Endocrinol (Oxf); 2022 Dec; 97(6):755-762. PubMed ID: 35920656
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome in familial partial lipodystrophy type 2 (FPLD2): basic and clinical aspects.
Gambineri A; Zanotti L
Nucleus; 2018; 9(1):392-397. PubMed ID: 30131000
[TBL] [Abstract][Full Text] [Related]
9. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.
Wojtanik KM; Edgemon K; Viswanadha S; Lindsey B; Haluzik M; Chen W; Poy G; Reitman M; Londos C
J Lipid Res; 2009 Jun; 50(6):1068-79. PubMed ID: 19201734
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinedione response in familial lipodystrophy patients with LMNA mutations: a case series.
Luedtke A; Boschmann M; Colpe C; Engeli S; Adams F; Birkenfeld AL; Haufe S; Rahn G; Luft FC; Schmidt HH; Jordan J
Horm Metab Res; 2012 Apr; 44(4):306-11. PubMed ID: 22274718
[TBL] [Abstract][Full Text] [Related]
11. A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies.
Treiber G; Flaus Furmaniuk A; Guilleux A; Medjane S; Bonfanti O; Schneebeli S; Bernard C; Le-Moullec N; Bakiri F; Pholsena M; Rollot O; Vatier C; Jarlet E; Jéru I; Lascols O; Darcel F; Domun B; Venault A; Venault S; Jacquemont ML; Doray B; Maiza JC; Cogne M; Vigouroux C; Nobécourt E
Eur J Endocrinol; 2021 Aug; 185(4):453-462. PubMed ID: 34292171
[TBL] [Abstract][Full Text] [Related]
12. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
[TBL] [Abstract][Full Text] [Related]
13. Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C.
Wong SP; Huda M; English P; Bargiota A; Wilding JP; Johnson A; Corrall R; Pinkney JH
Diabetologia; 2005 Dec; 48(12):2641-9. PubMed ID: 16320084
[TBL] [Abstract][Full Text] [Related]
14. The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks.
Briand N; Guénantin AC; Jeziorowska D; Shah A; Mantecon M; Capel E; Garcia M; Oldenburg A; Paulsen J; Hulot JS; Vigouroux C; Collas P
Hum Mol Genet; 2018 Apr; 27(8):1447-1459. PubMed ID: 29438482
[TBL] [Abstract][Full Text] [Related]
15. Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2.
Corsa CAS; Walsh CM; Bagchi DP; Foss Freitas MC; Li Z; Hardij J; Granger K; Mori H; Schill RL; Lewis KT; Maung JN; Azaria RD; Rothberg AE; Oral EA; MacDougald OA
Diabetes; 2021 Sep; 70(9):1970-1984. PubMed ID: 34088712
[TBL] [Abstract][Full Text] [Related]
16. The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy.
Vadrot N; Duband-Goulet I; Cabet E; Attanda W; Barateau A; Vicart P; Gerbal F; Briand N; Vigouroux C; Oldenburg AR; Lund EG; Collas P; Buendia B
Hum Mol Genet; 2015 Apr; 24(7):2096-109. PubMed ID: 25524705
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Dietary Intake, Leisure-Time Physical Activity, and Metabolic Profile in Women with Mutation in the LMNA Gene.
Monteiro L; Foss-Freitas MC; Navarro A; Pereira F; Coeli F; Carneseca E; Júnior RM; Foss M
J Am Coll Nutr; 2017; 36(4):248-252. PubMed ID: 28443701
[TBL] [Abstract][Full Text] [Related]
18. Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy.
Vantyghem MC; Vincent-Desplanques D; Defrance-Faivre F; Capeau J; Fermon C; Valat AS; Lascols O; Hecart AC; Pigny P; Delemer B; Vigouroux C; Wemeau JL
J Clin Endocrinol Metab; 2008 Jun; 93(6):2223-9. PubMed ID: 18364375
[TBL] [Abstract][Full Text] [Related]
19. [Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia].
Sorkina EL; Kalashnikova MF; Melnichenko GA; Tyulpakov AN
Ter Arkh; 2015; 87(3):83-87. PubMed ID: 26027246
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of Fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes.
Oldenburg AR; Delbarre E; Thiede B; Vigouroux C; Collas P
Hum Mol Genet; 2014 Mar; 23(5):1151-62. PubMed ID: 24108105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]